<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T06:33:31Z</responseDate>
  <request identifier="oai:figshare.com:article/34026959" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34026959</identifier>
        <datestamp>2026-09-29T17:39:04Z</datestamp>
        <setSpec>category_4</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_873</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;(A) Heat map of the highest affinity of soluble forms of TNFSF members for S100 proteins calculated from the SPR spectroscopy data (Table 1, Fig 4) and reported for soluble TNF/TRAIL [17,18]. The lowest ΔG value (kJ/mol) is given for each S100-cytokine interaction. (B) Correlation between the promiscuity parameter of S100 proteins [72] (columns) and number of TNFSF members specifically recogni&lt;/p&gt;</dc:title>
          <dc:creator>Victoria A. Rastrygina (25138459)</dc:creator>
          <dc:creator>Evgenia I. Deryusheva (7300229)</dc:creator>
          <dc:creator>Alexey S. Kazakov (6178109)</dc:creator>
          <dc:creator>Andrey S. Sokolov (25138462)</dc:creator>
          <dc:creator>Maria E. Permyakova (25138465)</dc:creator>
          <dc:creator>Ekaterina A. Litus (25138468)</dc:creator>
          <dc:creator>Vladimir N. Uversky (123421)</dc:creator>
          <dc:creator>Eugene A. Permyakov (13802061)</dc:creator>
          <dc:creator>Sergei E. Permyakov (13802058)</dc:creator>
          <dc:subject>Biochemistry</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Chemical Sciences not elsewhere classified</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>s100p evidences involvement</dc:subject>
          <dc:subject>equilibrium dissociation constants</dc:subject>
          <dc:subject>cellular communication mediated</dc:subject>
          <dc:subject>4 − 1bbl</dc:subject>
          <dc:subject>comprises 20 members</dc:subject>
          <dc:subject>treat several autoimmune</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>conserved binding sites</dc:subject>
          <dc:subject>tnfsf members tnf</dc:subject>
          <dc:subject>13 tnfsf members</dc:subject>
          <dc:subject>tnfsf members</dc:subject>
          <dc:subject>used clinically</dc:subject>
          <dc:subject>thereby suppressing</dc:subject>
          <dc:subject>targeting signaling</dc:subject>
          <dc:subject>targeted therapy</dc:subject>
          <dc:subject>soluble forms</dc:subject>
          <dc:subject>s100 proteins</dc:subject>
          <dc:subject>s100 family</dc:subject>
          <dc:subject>potentially important</dc:subject>
          <dc:subject>pleiotropic calcium</dc:subject>
          <dc:subject>p proteins</dc:subject>
          <dc:subject>interaction partners</dc:subject>
          <dc:subject>f89 residue</dc:subject>
          <dc:subject>explored selectivity</dc:subject>
          <dc:subject>cognate receptors</dc:subject>
          <dc:subject>clinical trials</dc:subject>
          <dc:subject>cell proliferation</dc:subject>
          <dc:subject>calcium leads</dc:subject>
          <dc:subject>bone loss</dc:subject>
          <dc:subject>binding proteins</dc:subject>
          <dc:subject>adaptive immunity</dc:subject>
          <dc:subject>24 μm</dc:subject>
          <dc:subject>21 non</dc:subject>
          <dc:subject>2 nm</dc:subject>
          <dc:description>&lt;p&gt;The columns for “promiscuous” and “orphan” S100 proteins [&lt;a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0341400#pone.0341400.ref073" target="_blank"&gt;73&lt;/a&gt;] are colored gray and white, respectively.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-29T17:38:55Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pone.0341400.g005</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_A_Heat_map_of_the_highest_affinity_of_soluble_forms_of_TNFSF_members_for_S100_proteins_calculated_from_the_SPR_spectroscopy_data_Table_1_Fig_4_and_reported_for_soluble_TNF_TRAIL_17_18_The_lowest_G_value_kJ_mol_is_given_for_each_S100-cyto/34026959</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
